Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > YEAR LOW

<< Previous

Bullboard Posts

Next >>

Comment by Mbxwatcheron Feb 01, 2023 1:48pm

186 Views

Post# 35260070

RE:RE:RE:RE:RE:RE:RE:RE:RE:YEAR LOW

In my opinion we are near the bottom. I expect the first quarter to be poor on the top line and a loss on the bottom line. I think the market knows that. I think it's possible we slide a few more cents after results. However, I do also think we start to rise after that. Both fundamentally, and in news. I think we see a corresponding rebound in stock price in the second half of the year.

understand that may not be everything we all want but I think that's what we are going to see.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?